We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

62 hedge funds and large institutions have $273M invested in Forte Biosciences in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

27% more funds holding

Funds holding: 49 → 62 (+13)

0.26% less ownership

Funds ownership: 2.62% → 2.36% (-0.26%)

11% less capital invested

Capital invested by funds: $306M → $273M (-$32.5M)

Holders
62
Holders Change
+13
Holders Change %
+26.53%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
20
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.6M
2
PA
Perceptive Advisors
New York
+$11M
3
SCM
Suvretta Capital Management
New York
+$9.01M
4
ACM
Altium Capital Management
New York
+$4.41M
5
Millennium Management
Millennium Management
New York
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$50.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$8.04M
3
Franklin Resources
Franklin Resources
California
-$7.49M
4
CS
Credit Suisse
Switzerland
-$3.1M
5
MS
Maven Securities
Jersey
-$3.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHP
26
Parkman Healthcare Partners
Connecticut
$1.07M +$4.91K +6 +0.5%
MA
27
MYDA Advisors
New York
$960K – – –
ECM
28
Endurant Capital Management
California
$946K +$904K +1,104 New
JGC
29
J. Goldman & Co
New York
$921K +$252K +308 +40%
MWNA
30
Marshall Wace North America
New York
$885K +$847K +1,034 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$855K +$817K +998 New
Northern Trust
32
Northern Trust
Illinois
$710K +$9.83K +12 +1%
IA
33
Insight Advisors
Pennsylvania
$689K +$623K +761 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$617K -$63.1K -77 -10%
CIBC Private Wealth Group
35
CIBC Private Wealth Group
Georgia
$606K – – –
TAM
36
Tocqueville Asset Management
New York
$428K +$152K +186 +59%
PAM
37
Premier Asset Management
Illinois
$414K +$396K +483 New
Squarepoint
38
Squarepoint
New York
$397K +$379K +463 New
Morgan Stanley
39
Morgan Stanley
New York
$366K -$165K -201 -32%
SSA
40
Schonfeld Strategic Advisors
New York
$347K +$332K +406 New
LPL Financial
41
LPL Financial
California
$339K -$20.5K -25 -6%
SC
42
Sepio Capital
Utah
$326K -$1.61M -1,963 -84%
Vontobel Holding
43
Vontobel Holding
Switzerland
$274K – – –
TCA
44
Transcend Capital Advisors
New Jersey
$274K +$262K +320 New
Citigroup
45
Citigroup
New York
$246K – – –
LP
46
LMR Partners
United Kingdom
$224K +$215K +262 New
BCM
47
Bridgeway Capital Management
Texas
$217K – – –
Marshall Wace
48
Marshall Wace
United Kingdom
$215K +$206K +251 New
VF
49
Virtu Financial
New York
$212K +$202K +247 New
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
$210K -$882K -1,077 -81%
1
2
3

FBRX Hedge Fund Activity: Q1 2021 in Review

62 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2021, worth a combined $273M — down 11% from $306M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FBRX positions and 7 closed out — a net gain of 13 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $13.6M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $50.5M.

  • 62 institutional investors held Forte Biosciences (FBRX) as of Q1 2021, up from 49 in Q4 2020.
  • Funds reported $273M of Forte Biosciences stock for Q1 2021, down 11% quarter-over-quarter.
  • 20 funds opened new Forte Biosciences positions in Q1 2021 and 7 closed out, a net change of +13 holders.
  • The largest Forte Biosciences buyer in Q1 2021 was Point72 Asset Management, an estimated $13.6M added.
  • The largest Forte Biosciences seller in Q1 2021 was ArrowMark Colorado Holdings, an estimated $50.5M sold.

Based on aggregated 13F filings for Q1 2021.